WebApr 6, 2024 · Kintara Therapeutics (KTRA) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund Activity. ... The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results ... WebOct 14, 2024 · Kintara Therapeutics, Inc. (NASDAQ:KTRA) announced fiscal year 2024 financial and operational results in a September 29 th press release and filed its 10-K with the SEC. Highlights for the fourth...
Investor Relations :: Kintara Therapeutics, Inc. (KTRA)
WebPSG Konsult delivered a 5% increase in recurring headline earnings per share and a return on equity of 22.7% for the current year. Total assets under management increased by 13% to R354.1 billion, comprising assets … WebKTRA Earnings Forecast. Next quarter’s earnings estimate for KTRA is -$0.10 with a range of -$0.10 to -$0.10. The previous quarter’s EPS was -$2.10. KTRA beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.76% of the time in the same period. In the last calendar year KTRA has ... design and mental health
Kintara Therapeutics, Inc. Common Stock (KTRA) - Nasdaq
WebKintara Announces Closing of $15.0 million Offering Priced at a Premium to Market. PR Newswire. Sep-27-21 05:04AM. KTRA: 2Q:21 Update. Zacks Small Cap Research. Sep-24-21 08:00AM. Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market. PR Newswire -21.43%. WebApr 11, 2024 · Kintara Therapeutics Inc KTRA Executive Morningstar Rating Rating as of Feb 17, 2024 Quote Chart Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation... WebApr 4, 2024 · As of April 03, 2024, Kintara Therapeutics Inc had a $5.9 million market capitalization, putting it in the 8th percentile of companies in the Biotechnology & Medical Research industry. Kintara Therapeutics Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. chubbottomlover twitter